Chad Therapeutics Reports Loss
- Share via
Chad Therapeutics Inc., Chatsworth, posted a net loss for the second quarter ended Sept. 30 of $434,000 compared to net income of $2,000 for the same period in 1998. Revenues fell to $3.4 million from $3.9 million.
Chad Therapeutics produces and develops oxygen systems and conserving devices for medical use.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
